RBLX

Reagents for clinical and medical laboratory use; reagents for medical and veterinary use in connection with biological materials; pharmaceutical preparations, namely, pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of diabetes; pharmaceuticals for the treatment of insulin resistance syndrome; pharmaceuticals for the treatment of diabetes-associated vascular disease; pharmaceuticals for the treatment of neurodegenerative diseases; pharmaceuticals for the treatment of angiogenesis-related diseases; pharmaceuticals for the treatment of arthritis; pharmaceuticals for the treatment of autoimmune diseases; and pharmaceuticals for the treatment of endometriosis